Prospective study of a tacrolimus-based quadruple immunosuppressive regimen: evaluation of safety and efficacy.
Lladó
L
L
Liver Transplantation Unit, CSU. Bellvitge, c/Feixa Llarga s/n, 09807 Hospitale L1, Barcelona, Spain.
Figueras
J
J
Ramos
E
E
Baliellas
C
C
Torras
J
J
Rafecas
A
A
Fabregat
J
J
Lama
C
C
Ibañez
L
L
Jaurrieta
E
E
D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D000961:Antilymphocyte Serum / Q000009:adverse effects / Q000627:therapeutic use; D001379:Azathioprine / Q000627:therapeutic use; D001786:Blood Glucose / Q000378:metabolism; D001794:Blood Pressure; D002784:Cholesterol / Q000097:blood; D003404:Creatinine / Q000097:blood; D004359:Drug Therapy, Combination; D005260:Female; D006084:Graft Rejection / Q000453:epidemiology; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D016031:Liver Transplantation / Q000276:immunology / Q000502:physiology*; D008297:Male; D008775:Methylprednisolone / Q000627:therapeutic use; D008875:Middle Aged; D008991:Monitoring, Physiologic; D011183:Postoperative Complications / Q000145:classification / Q000453:epidemiology*; D012189:Retrospective Studies; D012449:Safety; D016559:Tacrolimus / Q000097:blood / Q000493:pharmacokinetics / Q000627:therapeutic use*
D000305:Adrenal Cortex Hormones; D000961:Antilymphocyte Serum; D001786:Blood Glucose; D007166:Immunosuppressive Agents; D002784:Cholesterol; D003404:Creatinine; D001379:Azathioprine; D016559:Tacrolimus; D008775:Methylprednisolone